Preclinical Evidence That Trametinib Enhances the Response to Tyrosine Kinase Inhibitors in Acute Myeloid Leukemia

被引：1
作者：
Martinez-Lopez, Joaquin [1 ]
Linares, Maria [2 ]
Morales, Maria Luz [2 ]
Arenas, Alicia [1 ]
Zagorac, Ivana [3 ]
Ayala, Rosa M. [1 ]
Castro, Nerea [4 ]
Rapado, Inmaculada [5 ]
Quintela-Fandino, Miguel [3 ]
机构：
[1] Octubre Hosp, Dept Hematol, Madrid, Spain
[2] Hosp 12 Octubre, Inst Invest, Madrid, Spain
[3] Ctr Nacl Invest Oncol, Madrid, Spain
[4] Hosp Octubre, Ser Hematol, Madrid, Spain
[5] Hosp Univ 12 Octubre, Madrid, Spain
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.1581.1581
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1581
引用
收藏
页数：4
相关论文
共 50 条
  • [41] The Applicability of Tyrosine Kinase Inhibitors in Pediatric Chronic Myeloid Leukemia
    Ata, Fateen
    Ghasoub, Rola
    Benkhadra, Maria
    Fernyhough, Liam
    Aldapt, Mahmood
    Omar, Nabil E.
    Nashwan, Abdulqadir
    Mushtaq, Kamran
    Yassin, Mohamed A.
    BLOOD, 2023, 142
  • [42] Current Management of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors
    Haznedaroglu, Ibrahim C.
    TURKISH JOURNAL OF HEMATOLOGY, 2013, 30 (03) : 247 - 255
  • [43] Mutations of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia
    Kihel, I.
    Nachi, M.
    Bekadja, M. A.
    CLINICA CHIMICA ACTA, 2022, 530 : S334 - S335
  • [44] Unplanned discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia
    Tsutsumi, Yutaka
    Ito, Shinichi
    Ohigashi, Hiroyuki
    Shiratori, Souichi
    Teshima, Takanori
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (01) : 89 - 92
  • [45] Chronic myeloid leukemia and new tyrosine kinase inhibitors: confirmation
    Mahon, Francois-Xavier
    HEMATOLOGIE, 2006, 12 : 43 - 46
  • [46] Vitamin D and tyrosine kinase inhibitors in chronic myeloid leukemia
    Leonardo Campiotti
    Elena Bolzacchini
    Matteo Basilio Sutter
    Andrea Maria Maresca
    Anna Maria Grandi
    Luigina Guasti
    Internal and Emergency Medicine, 2018, 13 : 1337 - 1339
  • [47] New tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
    Kimura, Shinya
    Ashihara, Eishi
    Maekawa, Taira
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2006, 7 (05) : 371 - 379
  • [48] A safety review of tyrosine kinase inhibitors for chronic myeloid leukemia
    Ozmen, Deniz
    Alpaydin, Duygu Demet
    Saldogan, Muhammed Ali
    Eskazan, Ahmet Emre
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (04) : 411 - 423
  • [49] Tyrosine Kinase Inhibitors and Beyond for Chronic Myeloid Leukemia in Children
    Lia N. Phillips
    Nobuko Hijiya
    Pediatric Drugs, 2021, 23 : 241 - 251
  • [50] The Role of New Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
    Pophali, Priyanka A.
    Patnaik, Mrinal M.
    CANCER JOURNAL, 2016, 22 (01) : 40 - 50
12345